With offices in Europe, North America and APAC, ARCHIMED is a leading buyout investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include MedTech, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, Biopharma Products, Pharma Services and Animal & Environmental Health.
ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages over €8 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.
